Same Game, New (and More of the Same) Targets: How Government Enforcers Are Focusing on Healthcare and the Life Sciences
Event summary
Our speakers will break down the top government enforcement trends they are seeing and which ones they predict will be relevant to life sciences and healthcare companies in 2022. Our panelists will cover the pressing questions that innovative companies in the space are wondering:
- Where are we likely to see government enforcement action and scrutiny in the life sciences industry and what are key risk areas under the Anti-Kickback Statute?
- What are the hot issues in FCA litigation pertinent to life science and healthcare companies?
- What novel causes of enforcement action will we see reach beyond the traditional scope of existing regulations and target companies in the industry?
Our partners, some of whom have recently joined and have first-hand government experience, will provide thoughtful insight into these and other hotbed enforcement issues.
This webinar is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Deborah Argueta.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.